These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25912876)

  • 1. MicroRNA-129-5p inhibits hepatocellular carcinoma cell metastasis and invasion via targeting ETS1.
    Ma N; Chen F; Shen SL; Chen W; Chen LZ; Su Q; Zhang LJ; Bi J; Zeng WT; Li W; Huang XH; Wang Q
    Biochem Biophys Res Commun; 2015 Jun; 461(4):618-23. PubMed ID: 25912876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-324-5p Suppresses Hepatocellular Carcinoma Cell Invasion by Counteracting ECM Degradation through Post-Transcriptionally Downregulating ETS1 and SP1.
    Cao L; Xie B; Yang X; Liang H; Jiang X; Zhang D; Xue P; Chen D; Shao Z
    PLoS One; 2015; 10(7):e0133074. PubMed ID: 26177288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.
    Fang F; Chang RM; Yu L; Lei X; Xiao S; Yang H; Yang LY
    J Hepatol; 2015 Oct; 63(4):874-85. PubMed ID: 25998163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-362-5p promotes tumor growth and metastasis by targeting CYLD in hepatocellular carcinoma.
    Ni F; Zhao H; Cui H; Wu Z; Chen L; Hu Z; Guo C; Liu Y; Chen Z; Wang X; Chen D; Wei H; Wang S
    Cancer Lett; 2015 Jan; 356(2 Pt B):809-18. PubMed ID: 25449782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1.
    Huang XP; Hou J; Shen XY; Huang CY; Zhang XH; Xie YA; Luo XL
    FEBS J; 2015 Feb; 282(3):579-94. PubMed ID: 25475121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma.
    Chen JS; Li HS; Huang JQ; Dong SH; Huang ZJ; Yi W; Zhan GF; Feng JT; Sun JC; Huang XH
    Cancer Lett; 2016 May; 375(1):73-83. PubMed ID: 26944318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1.
    Hua S; Lei L; Deng L; Weng X; Liu C; Qi X; Wang S; Zhang D; Zou X; Cao C; Liu L; Wu D
    Oncogene; 2018 Mar; 37(12):1624-1636. PubMed ID: 29335523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-150-5p inhibits hepatoma cell migration and invasion by targeting MMP14.
    Li T; Xie J; Shen C; Cheng D; Shi Y; Wu Z; Zhan Q; Deng X; Chen H; Shen B; Peng C; Li H; Zhu Z
    PLoS One; 2014; 9(12):e115577. PubMed ID: 25549355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-181a-5p is downregulated in hepatocellular carcinoma and suppresses motility, invasion and branching-morphogenesis by directly targeting c-Met.
    Korhan P; Erdal E; Atabey N
    Biochem Biophys Res Commun; 2014 Aug; 450(4):1304-12. PubMed ID: 25058462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNA-145 targets v-ets erythroblastosis virus E26 oncogene homolog 1 to suppress the invasion, metastasis, and angiogenesis of gastric cancer cells.
    Zheng L; Pu J; Qi T; Qi M; Li D; Xiang X; Huang K; Tong Q
    Mol Cancer Res; 2013 Feb; 11(2):182-93. PubMed ID: 23233482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-199a-5p and let-7c cooperatively inhibit migration and invasion by targeting MAP4K3 in hepatocellular carcinoma.
    Liu L; Lu L; Zheng A; Xie J; Xue Q; Wang F; Wang X; Zhou H; Tong X; Li Y; Zhu X; Wu G
    Oncotarget; 2017 Feb; 8(8):13666-13677. PubMed ID: 28099144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of miR-485-5p in hepatocellular carcinoma progression targeting EMMPRIN.
    Sun X; Liu Y; Li M; Wang M; Wang Y
    Biomed Pharmacother; 2015 May; 72():58-65. PubMed ID: 26054676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-204-5p targeting SIRT1 regulates hepatocellular carcinoma progression.
    Jiang G; Wen L; Zheng H; Jian Z; Deng W
    Cell Biochem Funct; 2016 Oct; 34(7):505-510. PubMed ID: 27748572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-1 and microRNA-499 downregulate the expression of the ets1 proto-oncogene in HepG2 cells.
    Wei W; Hu Z; Fu H; Tie Y; Zhang H; Wu Y; Zheng X
    Oncol Rep; 2012 Aug; 28(2):701-6. PubMed ID: 22664953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of miR-299-5p inhibits the progression of hepatocellular carcinoma by targeting SIAH1.
    Jiang X; Shen X
    Bull Cancer; 2018 Oct; 105(10):873-883. PubMed ID: 30266288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A c-Myc/miR-17-5p feedback loop regulates metastasis and invasion of hepatocellular carcinoma.
    Liu D; Dong L; Liu Y; Wen D; Gao D; Sun H; Fan J; Wu W
    Tumour Biol; 2016 Apr; 37(4):5039-47. PubMed ID: 26546431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of miR-339-5p on invasion and prognosis of hepatocellular carcinoma.
    Wang YL; Chen CM; Wang XM; Wang L
    Clin Res Hepatol Gastroenterol; 2016 Feb; 40(1):51-6. PubMed ID: 26186881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA-9 suppresses the proliferation, invasion and metastasis of gastric cancer cells through targeting cyclin D1 and Ets1.
    Zheng L; Qi T; Yang D; Qi M; Li D; Xiang X; Huang K; Tong Q
    PLoS One; 2013; 8(1):e55719. PubMed ID: 23383271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-miR-197 inhibits migration in HCC cells by targeting KAI 1/CD82.
    Dai W; Wang C; Wang F; Wang Y; Shen M; Chen K; Cheng P; Zhang Y; Yang J; Zhu R; Zhang H; Li J; Zheng Y; Lu J; Zhou Y; Xu L; Guo C
    Biochem Biophys Res Commun; 2014 Apr; 446(2):541-8. PubMed ID: 24613834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer.
    Zhang Y; Yan LX; Wu QN; Du ZM; Chen J; Liao DZ; Huang MY; Hou JH; Wu QL; Zeng MS; Huang WL; Zeng YX; Shao JY
    Cancer Res; 2011 May; 71(10):3552-62. PubMed ID: 21444677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.